165 related articles for article (PubMed ID: 36206100)
1. LncRNA MSC-AS1, as an oncogene in melanoma, promotes the proliferation and glutaminolysis by regulating the miR-330-3p/ YAP1 axis.
Tian T; Luo B; Shen G; Ji G
Anticancer Drugs; 2022 Nov; 33(10):1012-1023. PubMed ID: 36206100
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
3. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MSC-AS1 motivates the development of melanoma by binding to miR-302a-3p and recruiting IGF2BP2 to elevate LEF1 expression.
Ma Y; Jin Y; Li C; Liu Y; Wang D
Exp Dermatol; 2021 Dec; 30(12):1764-1774. PubMed ID: 34218464
[TBL] [Abstract][Full Text] [Related]
5. The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.
Sun Y; Wang P; Yang W; Shan Y; Zhang Q; Wu H
Cancer Biol Ther; 2019; 20(6):729-739. PubMed ID: 30915884
[TBL] [Abstract][Full Text] [Related]
6.
Wan N; Yang W; Cheng H; Wang J
Cancer Biother Radiopharm; 2020 Oct; 35(8):596-604. PubMed ID: 32354225
[No Abstract] [Full Text] [Related]
7. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA BBOX1-AS1 promotes the progression of gastric cancer by regulating the miR-361-3p/Mucin 13 signaling axis.
Cai T; Peng B; Hu J; He Y
Bioengineered; 2022 May; 13(5):13407-13421. PubMed ID: 36700475
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
11. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
[TBL] [Abstract][Full Text] [Related]
12. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
Duan H; Li X; Chen Y; Wang Y; Li Z
Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
[TBL] [Abstract][Full Text] [Related]
14. LncRNA BBOX1-AS1 Contributes to the Progression of Esophageal Carcinoma by Targeting the miR-361-3p/COL5A1 Axis.
Lu YH; He DS; Li Y; Wang H; Ma RD
Biochem Genet; 2023 Aug; 61(4):1351-1368. PubMed ID: 36586008
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA VPS9D1-AS1 enhances proliferation, invasion, and epithelial-mesenchymal transition in endometrial cancer via miR-377-3p/SGK1.
Peng TF; Zhou YJ; Zhou J; Zhou Y; Li XC; Ouyang Q
Kaohsiung J Med Sci; 2022 Nov; 38(11):1048-1059. PubMed ID: 36245426
[TBL] [Abstract][Full Text] [Related]
16. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
17. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
[TBL] [Abstract][Full Text] [Related]
18. Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells.
Jin Y; Xu L; Zhao B; Bao W; Ye Y; Tong Y; Sun Q; Liu J
Cell Cycle; 2022 May; 21(9):908-920. PubMed ID: 35112997
[TBL] [Abstract][Full Text] [Related]
19. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis.
Zhang L; Zhao Y; Guan H; Zhang D
Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521
[TBL] [Abstract][Full Text] [Related]
20. LncRNA IGFL2-AS1 as a ceRNA Promotes HCT116 Cell Malignant Proliferation via the miR-433-3p/PAK4 Axis.
Liu S; Wang X; Zhang J; Liu Y; Li B
Turk J Gastroenterol; 2023 May; 34(5):497-507. PubMed ID: 36620931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
